Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06233110
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-01-22
Brief Title:
Ruxolitinib Plus Fostamatinib for Steroid Refractory CGvHD
Sponsor:
Stefanie Sarantopoulos MD PhD
Organization:
Duke University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-22
First Submit QC Date:
January 22 2024
Study First Post Date:
2024-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-26
Last Update Post Date:
2024-06-11
Last Update Post Date Type:
ACTUAL